SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : momo-T/FIF -- Ignore unavailable to you. Want to Upgrade?


To: keokalani'nui who wrote (3658)12/16/2005 12:22:02 PM
From: rkrw  Read Replies (1) | Respond to of 12215
 
Wilder,
Here's what I think I know:
*sp301 for diabetic nephropathy was a roche compound, roche had a callback option and passed.
*sp600 series is internally developed, 100% owned.

With the license/callbacks and internal programs in the same space it's not easy working through it.